Sermorelin is a growth hormone-releasing hormone (GHRH) analog — rather than supplying growth hormone directly, it signals your own pituitary gland to produce more of it.
What it’s studied for
Growth hormone naturally declines with age, and this decline is linked to changes in body composition, recovery capacity, and sleep quality — all relevant to the “getting back in shape after 40/50” conversation. Sermorelin’s appeal is that it works with your body’s own production rather than replacing it outright.
Research status
Sermorelin has a longer clinical history than many newer peptides, including past FDA-approved use, though current availability and regulatory status varies. Human trial data exists, but as with most age-management-focused peptide use, long-term outcome data is still limited.
Where this fits
This is the kind of compound that comes up in conversations about recovery capacity and sleep quality as we age — again, a conversation for a licensed provider familiar with your full health picture, not a self-directed decision.